Nanocarrier encapsulated recombinant ikba as potential therapeutic agent

Abstract

Protein therapeutics has been established as a potential weapon in anticancer armamentarium The limitations of conventional chemo and radiotherapy including poor response and undesired toxicity have led researchers to contrive new ways to combat cancer This quest has generated a whole array of new generation therapy starting from gene therapy and encompassing protein as well as nanoparticle mediated therapy Every approach has its own shortcoming e g proteins have a very limited half life